会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • 돼지 인플루엔자 바이러스 감염의 예방 또는 치료방법
    • 预防或治疗猪流感病毒感染的方法
    • KR1020130038600A
    • 2013-04-18
    • KR1020110103045
    • 2011-10-10
    • 녹십자수의약품(주)
    • 강보규문형준송대섭
    • A61K39/145A61K39/225A61K39/12A61P31/16
    • A61K39/12A61K39/145Y10S514/888
    • PURPOSE: A method for preventing or treating swine influenza virus infection is provided to effectively produce a composition for preventing or treating swine influenza virus infection and to effectively diagnose swine influenza virus infection. CONSTITUTION: A method for preventing or treating swine influenza virus infection comprises a step of administering a composition for preventing or treating swine influenza virus infection to a pig. The composition contains attenuated or inactivated swine influenza virus A/swine/Korea/GCVP-KS01/2009(H1N1)(deposit number KCTC 11848BP) or an immunogenicity subunit thereof. The attenuated swine influenza virus is prepared by treating with formalin or by subculture.
    • 目的:提供一种预防或治疗猪流感病毒感染的方法,以有效地产生预防或治疗猪流感病毒感染的组合物,并有效诊断猪流感病毒感染。 构成:预防或治疗猪流感病毒感染的方法包括向猪施用预防或治疗猪流感病毒感染的组合物的步骤。 该组合物含有减毒或灭活的猪流感病毒A /猪/韩国/ GCVP-KS01 / 2009(H1N1)(保藏号KCTC 11848BP)或其免疫原性亚单位。 减毒猪流感病毒通过用福尔马林或通过传代培养进行处理来制备。
    • 10. 发明授权
    • 돼지파보바이러스 및 돈단독균 복합 불활화 백신
    • 组合疫苗对猪细小病毒和白喉病毒
    • KR100906486B1
    • 2009-07-08
    • KR1020080093550
    • 2008-09-24
    • 녹십자수의약품(주)
    • 김영은윤용덕황정민
    • A61K39/12A61P37/00
    • A61K39/12A61K39/23C12N2750/14011
    • A complex vaccine which prevents porcine parvovirus and Erysipelothrixrhusiopathiae at the same time is provided to have immunogenicity and stabilize vaccination without immunological interference. A complex vaccine preventing porcine parvovirus and erysipelothrixrhusiopathiae comprises erysipelothrixrhusiopathiae inactivated bacteria antigen, erysipelothrixrhusiopathiae secretion antigen and porcine parvovirus antigen as an immunologically active ingredient. An aluminium hydroxide gel is mixed in the complex vaccine to have 20 volume%. The porcine pavovirus antigen is obtained by infecting a recombinant Baculovirus ] VP2-BV strain into a Sf-9 cell. The erysipelothrixrhusiopathiae inactivated bacteria antigen is obtained by culturing inactivated erysipelothrix rhusiopathiae T2 strain in the medium and inactivating with 0.2% of formalin. The erysipelothrixrhusiopathiae secretion antigen is obtained by centrifuging erysipelothrixrhusiopathiae bacteria bulk, collecting supernatant and filtering with cassette filter.
    • 提供同时防止猪细小病毒和白斑病毒性脑炎病毒的复合疫苗以具有免疫原性并且在没有免疫学干扰的情况下稳定疫苗接种。 一种复杂的疫苗预防猪细小病毒和毒蜥病毒性红斑疹病毒包括灭活细菌抗病毒,毒蜥红血球病毒血症病毒分泌抗原和猪细小病毒抗原作为免疫活性成分。 将复合疫苗中的氢氧化铝凝胶混合至20体积%。 通过将重组杆状病毒VP2-BV菌株感染到Sf-9细胞中获得猪疫病毒抗原。 通过在培养基中培养灭活的erysipelothrix rhusiopathiae T2菌株并用0.2%的福尔马林灭活获得灭活细菌病毒抗原。 通过离心分离大肠埃希氏梭菌属细菌,收集上清液并用盒式过滤器过滤获得毒蜥病毒性肺炎分泌抗原。